Kimberly Binaso-Stwalley, PharmD, CCP, FASCP, CGP
Director of Clinical Services
Managed Healthcare Associates
Florham Park, NJ
Ernest Mario College of Pharmacy
New Brunswick, New Jersey
Jay Wish, MD
Medical Director, Hemodialysis Services
University Hospitals of Cleveland
Professor of Medicine
Case Western Reserve University School of Medicine
Division of Nephrology
University Hospitals Case Medical Center
Several causes of anemia are highly prevalent in the elderly, especially chronic kidney disease. Clinicians working with elderly populations need to have a heightened awareness of causes of anemia, and they need to be prepared to identify and treat elderly patients appropriately. Recently, the FDA issued a public health advisory about reports of serious and life-threatening side effects associated with erythropoiesis-stimulating agents (ESAs). Multiple trials had been exploring the use of higher doses at extended intervals, but now the use of the lowest effective doses is being recommended. Clinicians are being urged to monitor individuals on treatment for potential adverse events. As guidelines for ESAs get updated based on new data, healthcare providers need to understand how these changes will impact their clinical practice, and they need to be educated on managing the various etiologies of anemia and using ESAs appropriately.
If you participated in the live audioconference or CD-ROM version of this program, you are not eligible to receive continuing education credit through this program. Program Developer/Facilitator
. Target Audience
Consultant pharmacists, VA pharmacists, nurses and geriatric nurse practitioners in LTC, LTC nursing directors, and LTC medical directors/attending physicians
Upon completion of this educational activity, the participant should be able to:
Identify key factors that put the elderly at risk for developing chronic anemia
Summarize the best approach for evaluating a LTC resident with anemia of CKD
Discuss the continuum of care by an interdisciplinary team when the elderly with anemia are prescribed ESAs and transferred among different facilities
Outline safe and effective dosing regimens of ESAs for LTC residents with anemia and CKD
Describe the optimal hemoglobin target range for those with CKD being treated with ESAs
It is the policy of ASCP, in accordance with the guidelines set forth by the Accreditation Council for Pharmacy Education, and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by ASCP and AKH prior to accreditation of the activity.
The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker¹s interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Kimberly Binaso-Stwalley, PharmD, CCP, FASCP, CGP, has served on the speakers bureau for Amgen Inc. and Ortho Biotech Products, L.P.
Jay Wish, MD, has served on the speakers bureau and advisory committees for Amgen Inc., Ortho Biotech Products, L.P., and Watson Pharmaceuticals Inc., L.P. He has provided product consultation services to Roche Pharmaceuticals.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Credit Statements
Pharmacy Continuing Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program (ACPE # 203-999-08-033-H01-P) was developed by ASCP and is approved for 1.0 Contact Hour (0.1 CEU).
Continuing Medical Education: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media, Inc. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education: AKH Inc. is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number 030803. AKH Inc. designates this educational activity for 1 contact hour which includes 0.5 pharmacology hour.
Nursing Continuing Education: NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation #1087. This program provides 1 contact hour by NADONA/LTC.
Commercial Support Statements
Supported by an educational grant from Ortho Biotech.
Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new cmecorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
Complete the short survey and click on "done."
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. This activity will require approximately 60 minutes to complete.
After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
Credit is awarded for scoring 70% or better on the post-test and completing a program evaluation. A statement of credit may be printed immediately after successfully completing and submitting the post-test and program evaluation. Instructions are provided on the post-test screen.
©2008 Medical Communications Media, Inc. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational program are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., or Ortho Biotech. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.